Clinical Trial Update: An Open,Single-centre Pilot Study of Efficacy and Safety of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO) [Phase 2]

View source ↗

Summary

Completed, single-centre Phase 2 open-label pilot study evaluating the efficacy and safety of topical MOB015B for distal subungual onychomycosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Distal Subungual Onychomycosis

Drugs mentioned

• MOB015B (MOB015B)

Snippet

Sponsor: Moberg Pharma AB | Conditions: Distal Subungual Onychomycosis | Phase 2 | Status: COMPLETED